Insulet Corporation to Report First Quarter 2007 Financial Results on Thursday, June 21st

Jun 12, 2007

Insulet Corporation to Report First Quarter 2007 Financial Results on Thursday, June 21st

Insulet Corporation to Report First Quarter 2007 Financial Results on Thursday, June 21st

BEDFORD, Mass., June 12 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer of the OmniPod Insulin Management System, announced plans to release its financial results for the first quarter 2007 on Thursday, June 21, 2007 after the close of the financial markets.


Insulet will also host a conference call at 8:00 a.m. Eastern Time on June 22, 2007 to discuss its first quarter 2007 financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.


To listen to the conference call, please dial 800.291.5365 for domestic callers and 617.614.3922 for international callers. The passcode is 51118211. A replay of the conference call will be available two hours after the start of the call through July 20, 2007 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 88765047. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://investors.insulet.com.


About Insulet Corporation


Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully- automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.


SOURCE Insulet Corporation


CONTACT:
Stephanie Marks for Insulet Corporation,
+1-877-PODD-IR1 (+1-877-763-3471),
ir@insulet.com
Web site: http://www.insulet.com